COMP <GO>
SMG vs FCX // GROSS PROFIT MARGIN
Scotts Miracle-Gro Company (The) (NYSE) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: SMG 7
— FCX 7
▲ GROSS PROFIT MARGIN LEADER: SMG
LAST: $62.24 (+0.60%) • MKT CAP: $3.60B
gross-margins
30.60%
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
gross-margins
26.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMG VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMG | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 30.60% | 26.10% | +4.50 | SMG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | 21.50% | -5.20 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 13.4x | -0.20 | SMG | /valuation <GO> |
| Free Cash Flow Yield | 7.60% | 4.71% | +2.89 | SMG | /fcf-yield <GO> |
| Operating Margin | 10.50% | 25.90% | -15.40 | FCX | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 8.80% | -4.50 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | -3.90% | 0.10% | -4.00 | FCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.28% | 0.91% | +3.37 | SMG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.32 | 3.08 | -0.76 | FCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | FCX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.5 | 30.2 | +45.30 | SMG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 0.95 | +0.08 | SMG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 40.1x | -17.00 | SMG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.60B | $94.98B | -$91.38B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMG REV | FCX REV | SMG GROSS % | FCX GROSS % | SMG FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.41B | $25.19B | 30.6% | 26.1% | $273.9M | $4.48B |
| FY 2024 | $3.55B | $25.17B | 23.9% | 29.3% | $583.5M | $6.03B |
| FY 2023 | $3.55B | $22.70B | 44.0% | 44.0% | $371.2M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMG // BETA 1.03
FCX // BETA 0.95